Friday, September 3, 2010
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP Europe
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.06 Aug 2009
White Papers
Focus Areas
Cover Stories
A personalised approach
Personalised medicines tailored to suit an individual’s genetic make-up could revolutionise the future of drug discovery. Frances Davies of...
Pushing the frontiers of disease prevention
Wayne Pisano runs the largest company in the world devoted entirely to human vaccines. As CEO of sanofi pasteur, he knows more than most about...
Vaccines for the world
Looking at the world’s vaccine market, GlaxoSmithKline is amongst the top players. The company’s vision is to challenge the world of vaccines...
Roundtables
-
Central testing
What are the benefits of integrating specialised testing into central laboratory services? NGP asked James Chennells, Global Head of Strategic Sourcing Pharma Development...Read more -
Omes and omics
Systems biology has had a huge impact on the drug discovery process. But do scientists agree on what this relatively new biological study field comprises? And what impact...Read more -
Tackling manufacturing challenges
By 2020, analysts predict, the pharmaceutical market will more than double to €829 billion ($1.3 trillion), with the E7 countries – Brazil, China, India, Indonesia, Mexico,...Read more -
Optimising sales force effectiveness
How do you recruit and continue to develop the highest quality sales management group in the industry? NGP asked Citobi, ADD IT Solutions, Innovex, and Wilson Learning Europa.Read more
Industry Analysts
-
Changing the definition of productivity an...
Over the past 30 years, high performance liquid chromatography (HPLC) has become an indispensable technology for the modern analytical laboratory. NGP talked to Dr Robert...Read more -
Finding value: education and the sales rep...
Ruth Slater of Axon Communications takes a look at the benefits of involving the sales force more closely in professional education activities.Read more -
Part of the process
Mike Rodd of Bürkert talks about continued collaboration with the pharmaceutical industry and plans for expansion of its facilities.Read more -
Metrohm International
Dr Alfred Steinbach, a technical writer in the marketing department of Metrohm International, looks at fully automated sample preparation for the content determination of...Read more
Executive Interviews
Innovating cardiac safety trials with new techn...
NGP asked Tosja K. Zywietz, Managing Director of Biosigna – Medical Diagnostics, how innovative technology will drive the future of the cardiac safety industry.
Read more
Water works
industry. Here, Eran Gabbai, CEO, CTO and inventor of Neowater describes how the technology could revolutionise research and development in the sector.
Read more
Outsourcing advantages
Outsourcing offers multiple benefits for pharmaceutical companies. NGP asked Marcel Velterop of Dr Reddy’s how it can help reduce costs, achieve higher levels of performance, free up resources for higher value activities and gain access to capabil...
Read more
NGP Europe Summit: Drug Discovery
1st - 3rd September 2010
The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.